NSF taken to task

Budget hearing raises still unresolved management and funding disparities

Written byTed Agres
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON, DC—The National Science Foundation (NSF) has failed to address fully half of the recommendations outlined last year by its own Inspector General to improve management and oversight of large infrastructure projects.

NSF Inspector General (IG) Christine Boesz told a Senate appropriations subcommittee Thursday that key recommendations "on developing new project and financial management policies and procedures remain unresolved by NSF management." With increased funding for large facilities and infrastructure projects underway "this issue needs to become one of greater urgency," she testified. "We are disappointed that the whole process could not have been accelerated."

Legislators have for several years questioned whether NSF's bureaucracy would hinder its ability to manage high-quality research, especially given a huge infusion of funds for "tools"—instrumentation and equipment, facilities, accelerators, telescopes and the like. NSF is seeking more than $1.34 billion in this area for FY 2004, nearly 25 percent of the agency's total budget.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery